Position in DXCM
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$25,578,115
+$1,898,496 QoQ
Shares Held
379,779
+0.7% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#130
of 971 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SEB Asset Management AB holds $440,245,210 across 10 Medical Devices names. DXCM ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
398,062 | $125,325,840 | |
| 2 | EW |
Edwards Lifesciences Corp
|
1,182,636 | $106,981,252 | |
| 3 | BSX |
Boston Scientific Corp
|
1,208,194 | $51,565,719 | |
| 4 | ABT |
Abbott Laboratories
|
490,775 | $44,532,923 | |
| 5 | STE |
STERIS plc
|
139,796 | $29,436,843 | |
| 6 | MDT |
Medtronic plc
|
367,665 | $28,762,432 | |
| 7 | DXCM |
Dexcom Inc
This page
|
379,779 | $25,578,115 | |
| 8 | PODD |
Insulet Corp
|
122,141 | $18,595,967 |
All Filings in DXCM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,578,115 | 379,779 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $23,679,619 | 377,064 | Shares | Sole | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||